Category: CAR T-cell Therapy

CAR-T Today and Tomorrow: Clinical Decision-Making and Patient Support

Tara Gregory, MD, Colorado Blood Cancer Institute, Denver, CO and Jay Spiegel, MD, Sylvester Comprehensive Cancer Center, Miami, FL

Key Insights from Attending ASH 2025

Lore Gruenbaum, PhD, Blood Cancer United, Washington, DC

Charting the Course of ALL: From Diagnosis to Advances

Catherine Lai, MD, MPH, University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia, PA

CAR-T in 2025: Advancements and the Road Ahead

Jason Westin, M.D., MS, FACP, MD Anderson Cancer Center, Houston, TX

CAR T-cell Therapy in 2024

Michael Tees, MD, MPH, Colorado Blood Cancer Institute, Denver, CO

Highlights from attending the 2023 ASH Annual Meeting

Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY

Scroll to Top